Department of Neurology Archive — Page 1 of 15

Dome-shaped EEG electrode cap covered with numerous numbered circular sensors and bundled white wires, shown against a blurred laboratory background.
October 28, 2026

Touch sensitivity in chronic tic disorders linked to early brain response

Researchers tested whether somatosensory gating, the brain’s ability to filter repetitive touch information, might help explain sensory over-responsivity.

Professional head-and-shoulders portrait of a smiling woman with shoulder-length blonde hair, wearing a black blazer over a patterned blouse, against an abstract white and pale-blue background.
September 23, 2026

Q+A: Angela Jefferson, PhD

Pat Byrne sits in a wheelchair wearing sunglasses and a coral patterned shirt while his wife, Michele, embraces him from behind beside a bright blue pool.
September 9, 2026

Why the bridge between Hearing and Speech Sciences and Neurology takes a good listener

Changes in a patient’s voice and speech patterns can be indicators of neurological disease and provide the key to a diagnosis.

David Curfman, MD, poses for a photo with his artwork in his office at The Vanderbilt Neurology Clinic. (photo by Erin O. Smith)
August 27, 2026

What do you find at the intersection of art and medicine?

David Curfman and Lealani Mae Acosta practice neurology at work and create art at home. The ways each discipline informs the other runs deeper than it may seem at first glance.

Fluorescence microscopy image showing a brightly colored, oval cell nucleus surrounded by threadlike blue and purple mitochondrial structures against a black background.
August 14, 2026

Discover what’s next in cancer at Aug. 22 symposium

The symposium is free and open to people affected by neurofibromatosis and schwannomatosis, as well as their families, loved ones and caregivers.

Glowing blue and magenta DNA double helix formed from particles, surrounded by streams of digital numbers and data-like light patterns.
August 5, 2026

Team’s AI agent to speed Alzheimer’s treatment

Patients who qualify for new Alzheimer’s disease therapies often wait weeks before receiving a first infusion.